Difficulty: Medium
Average Score: 62%
Testbank
A client with chronic renal failure has begun treatment with a colony-stimulating factor. What medication does the nurse anticipate administering to the client that will promote the production of blood cells?
Correct answer
C
Rationale
Epoetin alfa (Epogen) is a medication that stimulates the production of red blood cells, making it essential for clients with chronic renal failure who often experience anemia due to decreased erythropoietin production.
A: Etanercept (Enbrel) is a tumor necrosis factor (TNF) inhibitor used primarily for autoimmune conditions and does not promote blood cell production.
B: Infliximab (Remicade) is another TNF inhibitor that treats inflammatory diseases but does not address the hematopoietic needs of clients with chronic renal failure.
D: Adalimumab (Humira) is also a TNF inhibitor used for autoimmune disorders and does not have any role in stimulating blood cell production in this patient population.
A: Etanercept (Enbrel) is a tumor necrosis factor (TNF) inhibitor used primarily for autoimmune conditions and does not promote blood cell production.
B: Infliximab (Remicade) is another TNF inhibitor that treats inflammatory diseases but does not address the hematopoietic needs of clients with chronic renal failure.
D: Adalimumab (Humira) is also a TNF inhibitor used for autoimmune disorders and does not have any role in stimulating blood cell production in this patient population.